Recruiting PHASE2 INTERVENTIONAL 1-arm NCT04684147

Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase Ⅱ Clinical Trial of CNCT19 Cell Injection in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

Sponsor: Juventas Cell Therapy Ltd.

Conditions Relapsed or Refractory Acute Lymphoblastic Leukemia

Interventions single dose of CNCT19

Updated 8 times since 2021 Last updated: Aug 6, 2025 Started: Dec 24, 2020 Primary completion: Sep 22, 2022 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Relapsed or Refractory Acute Lymphoblastic Leukemia, this trial is actively recruiting participants. The trial is conducted by Juventas Cell Therapy Ltd. and has accumulated 8 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Recruiting PHASE2
Sep 2024 — Sep 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Oct 2023 — Jul 2024 [monthly]

Recruiting PHASE2
Apr 2023 — Oct 2023 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Mar 2022 — Apr 2023 [monthly]

Recruiting PHASE2
Mar 2021 — Mar 2022 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Juventas Cell Therapy Ltd.

Data source: Juventas Cell Therapy Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Chengdu, China , Chongqing, China , Guangzhou, China , Hangzhou, China , Sanhe, China , Shanghai, China , Tianjin, China , Wuhan, China , Xuzhou, China and 1 more location